Prolotherapy evidence for chronic low back pain remains inconclusive
A systematic review found mixed pain results, with too little detail in the abstract to judge how large or lasting any benefit was.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The review did not reach a firm conclusion about whether prolotherapy relieves chronic low back pain. Some included studies reported statistically significant pain reductions, while others found little or no improvement. These mixed findings leave the treatment's effectiveness uncertain; the abstract does not identify a group of patients with clearly established benefit.
The abstract omits study and participant counts, comparison treatments, follow-up times and numerical pain results. It therefore cannot show the size or durability of any benefit.
What the review examined
Researchers examined studies of prolotherapy, an injection approach, in people with persistent low back pain. Their stated outcome was pain reduction, so the review's reported results concern pain rather than demonstrated improvements in broader health.
How to read mixed results
The abstract describes results that differed across studies but offers no pooled estimate or explanation for those differences. Its conclusion is uncertainty, leaving open questions about which comparisons produced improvement and how meaningful those changes were.
The original publication
Prolotherapy as a Regenerative Treatment in the Management of Chronic Low Back Pain: A Systematic Review.
Mociu SI, Nedelcu AD, Lupu AA et al.
Medicina (Kaunas) · 2025
- PubMed ID
- 41010979
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.